Evidence map

ArticleMetabolites2023

Developing A Baseline Metabolomic Signature Associated with COVID-19 Severity: Insights from Prospective Trials Encompassing 13 U.S. Centers.

Kaifeng Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 37999202